POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 14 JUNE 2024 AND RETIREMENT OF EXECUTIVE DIRECTORS

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Kaisa Health Group Holdings Limited (Incorporated in Bermuda with limited liability) (Stock Code: 876) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 14 JUNE 2024 AND RETIREMENT OF EXECUTIVE DIRECTORS References are made to the circular (the “Circular”) and the notice of the 2024 AGM (the “Notice”) of Kaisa Health Group Holdings Limited (the “Company”) both dated 30 April 2024. Unless the context otherwise required terms used in this announcement shall have the same meanings as defined in the Circular.The Board is pleased to announce that at the 2024 AGM held on 14 June 2024 allresolutions proposed at the 2024 AGM as set out in the Notice (the “ProposedResolutions”) were duly passed by the Shareholders by way of poll.As at the date of the 2024 AGM the total number of issued Shares was 5042139374 Shares which was the total number of Shares entitling the Shareholders to attend and vote on the Proposed Resolutions at the 2024 AGM. There were no Shares entitling the holder to attend but abstain from voting in favour of the Proposed Resolutions at the 2024 AGM as set out in Rule 13.40 of the Listing Rules and no Shareholders are required under the Listing Rules to abstain from voting.The Company’s Hong Kong branch share registrar Computershare Hong Kong Investor Services Limited was appointed and acted as the scrutineer for the vote-taking at the 2024 AGM. Mr. Luo Jun the executive Director attended the 2024 AGM physically and all the remaining Directors attended the 2024 AGM by telephone conference. 1The poll results were as follows: Number of Votes (%) (Note 3) Ordinary Resolutions For Against 1. To consider adopt and receive the audited 2487225331 0 consolidated financial statements of the Company (100%) (0%) and its subsidiaries (collectively the “Group”) a n d t h e r e p o r t s o f t h e d i r e c t o r s a n d t h e independent auditor of the Company for the year ended 31 December 2023. 2. To re-elect Mr. Wu Tianyu as an executive director of the Company. (Note 1) 3. To re-elect Mr. Zhang Huagang as an executive director of the Company. (Note 1) 4. To re-elect Dr. Lyu Aiping as an independent 2487225331 0 non-executive director of the Company. (100%) (0%) 5. To author ise the board of d i rec tors of the 2487225331 0 Company to appoint additional directors as and (100%) (0%) w h e n t h e b o a r d c o n s i d e r s n e c e s s a r y a n d appropriate. 6. To author ise the board of d i rec tors of the 2487225331 0 Company to f i x t he r e spec t i ve d i r ec to r s ’ (100%) (0%) remuneration. 7. To re-appoint Elite Partners CPA Limited as 2487225331 0 auditor of the Company and to authorise the board (100%) (0%) o f d i r e c t o r s o f t h e C o m p a n y t o f i x t h e i r remuneration. 8. To give a general mandate to the directors to buy 2487225331 0 back the Company’s shares not exceeding 10% of (100%) (0%) total number of shares of the Company in issue as at the date of passing of this resolution. (Note 2) 9. To give a general mandate to the directors to 2486955331 270000 issue allot and deal with additional shares of the (99.989145%) (0.010855%) Company not exceeding 20% of the total number of shares of the Company in issue as at the date of passing of this resolution. (Note 2) 10. To extend the general mandate granted to the 2486955331 270000 directors to issue allot and deal with additional (99.989145%) (0.010855%) shares in the capital of the Company by the total n u m b e r o f s h a r e s b o u g h t b a c k b y t h e Company.(Note 2) 2Notes: 1. References is made to the announcement of the Company dated 27 May 2024. As Mr. Wu Tianyu and Mr. Zhang Huagang each of them did not offer himself for re-election at the 2024 AGM the ordinary resolutions numbered 2 and 3 in respect of Mr. Wu’s re-election as an executive Director and Mr. Zhang’s re-election as an executive Director respectively as set out in the Notice were no longer applicable and were not put forward for consideration and approval by the Shareholders at the 2024 AGM. 2. For the full text of the Proposed Resolutions please refer to the Notice as contained in the Circular. 3. The number of votes and the percentage of the total votes as stated above are based on the total number of issued Shares held by the Shareholders who attended and voted at the 2024 AGM in person by authorised representative or by proxy.As more than 50% of the votes were cast in favour of each of the Proposed Resolutions all of them were duly passed as ordinary resolutions of the Company at the 2024 AGM.By order of the Board Kaisa Health Group Holdings Limited Kwok Ying Shing Chairman and Executive Director Hong Kong 14 June 2024 As at the date of this announcement the Board comprises Mr. Kwok Ying Shing (Chairman) Mr. Luo Jun (Co-Vice Chairman) as executive Directors; and Dr. Liu Yanwen Dr. Lyu Aiping and Ms. Li Zhiying as independent non-executive Directors. 3